About Veritas Genetics
Veritas Genetics is a company based in Danvers (United States) founded in 2014 by George M Church was acquired by LetsGetChecked in March 2022. Veritas Genetics has raised $53.38 million across 5 funding rounds from investors including LetsGetChecked, Simcere Pharma and Philab. Veritas Genetics has completed 2 acquisitions, including Curoverse and NIMGenetics. Veritas Genetics offers products and services including myGenome, myGeneticRisk, myHealthScore, myPrenatal, and CardioRisk. Veritas Genetics operates in a competitive market with competitors including 23andMe, Foundation Medicine, GreenLight Biosciences, Color and Personalis, among others.
- Headquarter Danvers, United States
- Founders George M Church
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Veritas Genetics, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$53.38 M (USD)
in 5 rounds
-
Latest Funding Round
$4.64 M (USD), Debt – Conventional
Mar 09, 2018
-
Investors
LetsGetChecked
& 4 more
-
Employee Count
Not available
-
Investments & Acquisitions
Curoverse
& 1 more
-
Acquired by
LetsGetChecked
(Mar 29, 2022)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Veritas Genetics
Veritas Genetics offers a comprehensive portfolio of products and services, including myGenome, myGeneticRisk, myHealthScore, myPrenatal, and CardioRisk.
Whole genome sequencing for disease prevention and risk analysis
Test for assessing risks of common genetic diseases
Analysis of drug responses based on genetic data
Non-invasive screening for chromosomal abnormalities
Evaluation of hereditary cardiovascular disease risks
People of Veritas Genetics
Unlock access to complete
Unlock access to complete
Funding Insights of Veritas Genetics
Veritas Genetics has successfully raised a total of $53.38M across 5 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $4.64 million completed in March 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Veritas Genetics
Veritas Genetics has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include LetsGetChecked, Simcere Pharma and Philab.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
early & growth stage tech and life sciences focused VC firm investing primarily in China and the US
|
Locked | Locked | Locked | |
|
Life science equipment and diagnostic services are provided.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Veritas Genetics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Veritas Genetics
Veritas Genetics has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Curoverse and NIMGenetics.
Investment portfolio details for Veritas Genetics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Genomic and biomedical Big Data infrastructure is provided.
|
Locked | Locked | 2010 | Locked | |
|
Diagnostic solutions are developed using microarray and next-generation sequencing technologies.
|
Locked | Locked | 2007 | Locked |
Complete acquisition details for Veritas Genetics
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Veritas Genetics
Detailed financials for Veritas Genetics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Veritas Genetics Comparisons
Peer comparison for Veritas Genetics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Veritas Genetics
Veritas Genetics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as 23andMe, Foundation Medicine, GreenLight Biosciences, Color and Personalis, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits
|
|
| Locked | Locked | Locked |
Genomics-based diagnostic tests for cancer are provided.
|
|
| Locked | Locked | Locked |
RNA-based platform for life sciences is developed by GreenLight Biosciences.
|
|
| Locked | Locked | Locked |
Cancer care is delivered through a virtual clinic by Color.
|
|
| Locked | Locked | Locked |
Genomic sequencing and diagnosis software is provided for healthcare.
|
|
| Locked | Locked | Locked |
Drug and companion diagnostics for multi-drug resistant cancers are developed.
|
Detailed competitors of Veritas Genetics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Veritas Genetics
Complete news archive for Veritas Genetics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Veritas Genetics
Veritas Genetics was founded in 2014 and raised its 1st funding round 1 year after it was founded.
Veritas Genetics is headquartered in Danvers, United States. It is registered at Danvers, Massachusetts, United States.
Veritas Genetics is a funded company, having raised a total of $53.38M across 5 funding rounds to date.
Veritas Genetics was founded in 2014 and is based in Danvers, United States. Genetic testing services in the biotechnology sector are provided by the company. Initial products involve analysis of patient saliva samples for the BRCA gene to evaluate risks of breast and ovarian cancer. The Mygenome test, as the latest offering, enables whole-genome sequencing to identify health conditions and lifestyle traits.
Veritas Genetics's top competitors include 23andMe, GreenLight Biosciences and Foundation Medicine.
Veritas Genetics offers myGenome, myGeneticRisk, myHealthScore, myPrenatal, and CardioRisk.
Veritas Genetics has made 2 acquisitions, including Curoverse, and NIMGenetics.
Veritas Genetics has 5 investors. Key investors include LetsGetChecked, Simcere Pharma, Philab, Lilly Asia Ventures, and Trustbridge Partners.